Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson’s Disease – Video




Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson #39;s Disease
On Thursday, January 8, RYTARY, an extended release formulation of carbidopa/levodopa, was approved by the US Food and Drug Administration (FDA) for the treatment of Parkinson #39;s disease. The...

By: parkinsonsdiseasefdn

Continue reading here:
Dr. James Beck Discusses FDA Approval of RYTARY for Parkinson's Disease - Video

Related Posts

Comments are closed.